BrainsWay Reports 34% Revenue Growth and Margin Expansion in Q3 2026
BrainsWay (BWAY) reported strong third-quarter 2026 financial results, highlighted by a 34% year-over-year revenue increase to $18.1 million. The company's growth is driven by the successful shipment of 130 Deep TMS systems—a 44% increase from the previous year—bringing its global installed base to over 2,000 units. This expansion is facilitating a shift toward recurring revenue through multiyear customer contracts. Operational efficiency also improved, with gross margins rising to 78%, up from 75% in the prior year, due to manufacturing scale and lower component costs. Furthermore, the company reached a significant milestone in patient accessibility as insurance reimbursement for its SWIFT accelerated protocol now covers over 70 million lives in the United States. Management indicated that full-year results are trending toward the upper end of previous guidance.
Tickers: $BWAY
Topics: Gross Margin Insurance Reimbursement Product Shipments Revenue Growth